FAQs

MADE WITH AND FOR PEOPLE WITH PARKINSON’S

FREQUENTLY ASKED QUESTIONS

Please find below a list of our frequently asked questions, including how the device is worn and when it will be available for use. If you have a question that isn’t answered below, please get in touch and one of our team will get back to you.

We have had the privilege of working with people with Parkinson’s since 2014. The stories and experiences have moved us and we think it is important to help those with the condition that currently has no cure.

We have gained amazing insights from participants, their loved ones and specialists. With the CUE device, we have a chance at alleviating some of the challenging symptoms of Parkinson’s disease in a novel and non-invasive way.

We are committed to making a real positive impact and bringing research directly from the bench to the hands of people with Parkinson’s.

CUE1 is a non-invasive device that sits on the sternum. It uses a unique technique to ensure it is comfortable for people with Parkinson’s to wear.

Movement itself involves a complex interplay of the nervous system and the musculoskeletal system. The scientific community’s understanding of movement has developed significantly over the last few decades. We are increasingly appreciating the importance of the sensory system and there is growing evidence that modulation of this can change brainwave patterns and improve movement across different tasks. It is a non-invasive, non-pharmacological intervention that can improve symptoms above medication alone.

The technology used in CUE1 is based on feedback, user testing and published research. Our user testing showed positive results with the CUE device across a range of motor tasks including tapping, walking and more real-life experiments. Our participants covered most of the Hoehn Yahr stages of Parkinson’s Disease and included someone who had had DBS surgery. Although we had positive results in all participants, we aim to carry out further testing with more people and over a longer duration. We will continue to develop the CUE even after release to explore just how far we can improve symptoms and quality of life and tailor it to the feedback of users.

At the moment we are recruiting for public patient involvement(PPI) for review of the clinical trial protocol we are currently preparing for. If you are interested in taking part in one of our future clinical trials and are based in the UK, we’d love to hear from so please get in touch.

We share the frustration of people with Parkinson’s who take part in clinical research and university projects who never see their hard work culminate in an actual product that they can use. We are committed to bringing the CUE1 device to people with Parkinson’s as soon as possible. We are currently working on all of the regulatory processes to ensure the device is made to the high standard you can trust.